We are monitoring the impact of COVID-19 on Metabolomics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3318
Share on
Share on

Global Metabolomics Market Analysis - By Product (Metabolomic Bioinformatics, Metabolomic Tools and Services), Indication (Cancer, Cardiovascular Disorders, Inborn errors, Neurological Errors and Other Indications), Application (Nutrigenomics, Toxicology, Biomarker & Drug Discovery, Functional Genomics, Personalized Medicine and Other Applications ) & By Region - Industry Size, Share, Growth, Trends, Forecast | 2019 – 2024

Pulished: February, 2020
ID: 3318
Pages: 175

Global Metabolomics Market Size & Growth (2019 - 2024)

As per our research analysis, the size of the Global Metabolomics Market was worth USD 1770 Million in 2019 and estimated to grow at a CAGR of 19%, to reach USD 4220 Million by 2024 during the forecast period 2019 - 2024.

Metabolomics is the substantial scale research of little atoms, ordinarily known as metabolites, inside cells, biofluids, tissues or living beings. Aggregately, these little particles and their associations inside an organic framework are known as the metabolome. Metabolomics is a capable approach since metabolites and their concentration not like other "omics" measures, straightforwardly reflect the hidden biochemical movement and condition of cells/tissues. Consequently, metabolomics represents atomic phenotype. The global Metabolomics market is developing at an exceptionally quick pace.

The developing acceptance of metabolomics in customized medicines is one of the key variables boosting the development of the market. The expanding biotech innovative work and pharmaceutical consumption are prompting persistent headways in innovation, spelling development for the worldwide metabolomics market. Then again, there are issues with respect to information handling and information examination, which can represent a test for the market.

The high cost of instruments and devices can likewise be an issue. Further, the requirement for very much qualified specialists and the absence of the same is limiting the development of the metabolomics market. Be that as it may, the undiscovered markets in rising countries will goad new development open doors for market players.

Increasing demand for personalized medicines is expected to boost the growth opportunities for the metabolomics market. The increasing frequency of chronic degenerative diseases like cancer, cardiovascular diseases, and neurological disorders is likely to offer lucrative growth opportunities for the growth of the metabolomics market. Increasing economies of developing countries such as China, India, Brazil, and Middle East are likely to offer opportunities for the key stakeholders. The emergence of novel and innovative products owing to technological developments especially biomarkers are contributing to the growth of the market and are anticipated to create more opportunities for the growth of the metabolomics market during the forecast period.

Recent developments:

  • In April 2019, Agilant Company has launched a set of new products for the laboratories that are associated with metabolomics research, food testing, environmental screening, and various types of analytical pursuits. Products are designed mainly for improving the efficiency of analytical and business outcomes.
  • Metabolon Inc. has expanded its services and product portfolio regarding the metabolomics by acquiring Metabolomic Discoveries GmbH in 2017.
  • Murdoch University has entered into a strategic collaboration with Bruker Company in September 2019. The major objective of this collaboration is to develop phenomics for the diagnosis of diseases and to enhance personalized health. 

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Technology, Product, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, APAC, Latin America, Middle East and Africa

Companies Analysed

Agilent Technologies, Inc. (U.S.), Human Metabolome Technologies, Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), Danaher Corporation (U.S.), Biocrates Life Sciences AG (Austria), and Waters Corporation (U.S.)

 

This research report on the Global Metabolomics Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Metabolomics Market Analysis - By Product:

  • Metabolomic Instruments                               
    • Separation Techniques   
      • Gas Chromatography (GC)
      • Capillary Electrophoresis (CE)
      • High-performance Liquid Chromatography (HPLC)
      • Ultra-performance Liquid Chromatography (UPLC)
    • Detection Tools 
      • Mass Spectrometry
      • Nuclear Magnetic Resonance Spectroscopy
      • Surface-Based Mass Analysis
  • Metabolomics Bioinformatics Tools and Services                   
    • Bioinformatics Tools & Databases              
    • Bioinformatics Services  

On the basis of product, the metabolomics instruments segment is ruling the global metabolomics market and it has contributed the highest share to the market among the products and services. The adoption of metabolomics increasing rapidly owing to smooth technological operations leading to high workflow efficiency, and other factors such as reliability, precision, processing of data are highly transparent, are propelling the growth of metabolomics instruments segment.

Metabolomics Market Analysis - By Indication:

  • Cancer
  • Cardiovascular Disorders
  • Inborn errors
  • Neurological Errors
  • Other Indications

Metabolomics Market Analysis - By Application:

  • Nutrigenomics
  • Toxicology
  • Biomarker & Drug Discovery
  • Functional Genomics
  • Personalized Medicine
  • Other Applications

On the Basis of Application, biomarker discovery segment has contributed a significant share in the overall revenue of the metabolomics market and is expected to be a rapidly growing segment among the applications during the forecast period. The adoption of metabolic biomarkers is consistently increasing for controlling diseases at the metabolic level due to enhancement in their reliability and efficiency, which is eventually leading to the growth of the biomarker discovery market. Collaborations between the biotechnology firms and pharmaceutical companies for validation and discovery of biomarkers which is likely to propel the growth of personalized medicine segment during the forecast period.

Regional Analysis:

On the Basis of Region, North America is estimated to constitute the largest share in this market, while the Asia Pacific region is expected to witness the fastest growth and overtake North America, being the second-largest shareholder for the market during the forecast period.

Prominent companies playing a major role in Global Metabolomics Market Profiled in the Report are:

  1. Agilent Technologies, Inc. (U.S.)
  2. Human Metabolome Technologies, Inc. (Japan)
  3. Thermo Fisher Scientific, Inc. (U.S.)
  4. LECO Corporation (U.S.)
  5. Bruker Corporation (U.S.)
  6. Shimadzu Corporation (Japan)
  7. Metabolon Inc. (U.S.)
  8. Danaher Corporation (U.S.)
  9. Biocrates Life Sciences AG (Austria)
  10. Waters Corporation (U.S.) 

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

2.2.1 Secondary Research                           

2.2.2 Primary Research                 

2.2.3 Econometric Modelling                      

2.2.4 Expert Validation                  

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 Product        

5.1.1 Metabolomic Instruments                               

                5.1.1.1Separation Techniques   

5.1.1.1.1 Gas Chromatography (GC)

5.1.1.1.2 Capillary Electrophoresis (CE)

5.1.1.1.3 High-performance Liquid Chromatography (HPLC)

5.1.1.1.4 Ultra-performance Liquid Chromatography (UPLC)

                5.1.1.2 Detection Tools 

5.1.1.2.1 Mass Spectrometry

5.1.1.2.2 Nuclear Magnetic Resonance Spectroscopy

5.1.1.2.3 Surface-Based Mass Analysis

5.1.2 Metabolomics Bioinformatics Tools and Services                   

                5.1.2.1 Bioinformatics Tools & Databases              

                5.1.2.2 Bioinformatics Services  

5.1.3 Y-o-Y Growth Analysis, By Product                               

5.1.4 Market Attractiveness Analysis, By Product                             

5.1.5 Market Share Analysis, By Product                               

                5.2 Indication    

5.2.1 Cancer                      

5.2.2 Cardiovascular Disorders                   

5.2.3 Inborn errors                         

5.2.4 Neurological Errors                              

5.2.5 Other Indications                 

5.2.4 Y-o-Y Growth Analysis, By Indication                           

5.2.5 Market Attractiveness Analysis, By Indication                         

5.2.6 Market Share Analysis, By Indication                           

                5.3 Application 

5.3.1 Nutrigenomics                       

5.3.2 Toxicology                               

5.3.3 Biomarker & Drug Discovery                            

5.3.4 Functional Genomics                          

5.3.5 Personalized Medicine                      

5.3.6 Other Applications

5.3.7 Y-o-Y Growth Analysis, By Application                         

5.3.8 Market Attractiveness Analysis, By Application                       

5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis                              

                6.1 Introduction               

6.1.1 Regional Trends                    

6.1.2 Impact Analysis                     

6.1.3 Y-o-Y Growth Analysis                        

                6.1.3.1 By Geographical Area     

                6.1.3.2 By Product           

                6.1.3.3 By Indication       

6.1.4 Market Attractiveness Analysis                      

                6.1.4.1 By Geographical Area     

                6.1.4.2 By Product           

                6.1.4.3 By Indication       

6.1.5 Market Share Analysis                       

                6.1.5.1 By Geographical Area     

                6.1.5.2 By Product           

                6.1.5.3 By Indication       

                6.2 North America          

6.1.1 Introduction                           

6.1.2 United States                         

6.1.3 Canada                     

                6.3 Europe         

6.2.1 Introduction                           

6.2.2 U.K                             

6.2.3 Spain                         

6.2.4 Germany                 

6.2.5 Italy                            

6.2.6 France                       

                6.4 Asia-Pacific 

6.3.1 Introduction                           

6.3.2 China                         

6.3.3 India                          

6.3.4 Japan                         

6.3.5 Australia                   

6.3.6 South Korea                           

                6.5 Latin America             

6.4.1 Introduction                           

6.4.2 Brazil                          

6.4.3 Argentina                

6.4.4 Mexico                     

6.4.5 Rest of Latin America                          

                6.6 Middle East & Africa               

6.5.1 Introduction                           

6.5.2 Middle-East                            

6.5.3 Africa                         

7.Strategic Analysis                        

                7.1 PESTLE analysis         

7.1.1 Political                     

7.1.2 Economic                 

7.1.3 Social                         

7.1.4 Technological                         

7.1.5 Legal                          

7.1.6 Environmental                       

                7.2 Porter’s Five analysis              

7.2.1 Bargaining Power of Suppliers                        

7.2.2 Bargaining Power of Consumers                    

7.2.3 Threat of New Entrants                     

7.2.4 Threat of Substitute Products and Services                              

7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                         

                8.1 Waters Corporation (U.S.)   

8.1.1 Overview                 

8.1.2 Product Analysis                   

8.1.3 Financial analysis                  

8.1.4 Recent Developments                       

8.1.5 SWOT analysis                       

8.1.6 Analyst View                          

                8.2 Agilent Technologies, Inc. (U.S.)        

                8.3 Human Metabolome Technologies, Inc. (Japan)        

                8.4 Thermo Fisher Scientific, Inc. (U.S.) 

                8.5 LECO Corporation (U.S.)        

                8.6 Bruker Corporation (U.S.)    

                8.7 Shimadzu Corporation (Japan)           

                8.8 Metabolon Inc. (U.S.)            

                8.9 Danaher Corporation (U.S.) 

                8.10 Biocrates Life Sciences AG (Austria)              

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10.Market Outlook and Investment Opportunities                          

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Metabolomics Market By Region, From 2019-2024 ( USD Million )
  2. Global Metabolomics Market By Product, From 2019-2024 ( USD Million )
  3. Global GC Market By Region, From 2019-2024 ( USD Million )
  4. Global Bioinformatics Market By Region, From 2019-2024 ( USD Million )
  5. Global Mass Spectroscopy Market By Region, From 2019-2024 ( USD Million )
  6. Global HPLC Market By Region, From 2019-2024 ( USD Million )
  7. Global UPLC Market By Region, From 2019-2024 ( USD Million )
  8. Global NMRS Market By Region, From 2019-2024 ( USD Million )
  9. Global Surface Based analysis Market By Region, From 2019-2024 ( USD Million )
  10. Global Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  11. Global Oncology Market By Region, From 2019-2024 ( USD Million )
  12. Global Cardiology Market By Region, From 2019-2024 ( USD Million )
  13. Global Inborn Errors Market By Region, From 2019-2024 ( USD Million )
  14. Global Metabolomics Market By Application, From 2019-2024 ( USD Million )
  15. Global Nutrigenomics Market By Region, From 2019-2024 ( USD Million )
  16. Global Toxicology Market By Region, From 2019-2024 ( USD Million )
  17. Global Biomarker & Drug Discovery Market By Region, From 2019-2024 ( USD Million )
  18. North America Metabolomics Market By Product, From 2019-2024 ( USD Million )
  19. North America GC Market By Region, From 2019-2024 ( USD Million )
  20. North America Bioinformatics Market By Region, From 2019-2024 ( USD Million )
  21. North America Mass Spectroscopy Market By Region, From 2019-2024 ( USD Million )
  22. North America HPLC Market By Region, From 2019-2024 ( USD Million )
  23. North America UPLC Market By Region, From 2019-2024 ( USD Million )
  24. North America NMRS Market By Region, From 2019-2024 ( USD Million )
  25. North America Surface Based analysis Market By Region, From 2019-2024 ( USD Million )
  26. North America Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  27. North America Oncology Market By Region, From 2019-2024 ( USD Million )
  28. North America Cardiology Market By Region, From 2019-2024 ( USD Million )
  29. North America Inborn Errors Market By Region, From 2019-2024 ( USD Million )
  30. North America Metabolomics Market By Application, From 2019-2024 ( USD Million )
  31. North America Nutrigenomics Market By Region, From 2019-2024 ( USD Million )
  32. North America Toxicology Market By Region, From 2019-2024 ( USD Million )
  33. North America Biomarker & Drug Discovery Market By Region, From 2019-2024 ( USD Million )
  34. United States Metabolomics Market By Product, From 2019-2024 ( USD Million )
  35. United States Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  36. United States Metabolomics Market By Application, From 2019-2024 ( USD Million )
  37. Canada Metabolomics Market By Product, From 2019-2024 ( USD Million )
  38. Canada Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  39. Canada Metabolomics Market By Application, From 2019-2024 ( USD Million )
  40. Europe Metabolomics Market By Product, From 2019-2024 ( USD Million )
  41. Europe GC Market By Region, From 2019-2024 ( USD Million )
  42. Europe Bioinformatics Market By Region, From 2019-2024 ( USD Million )
  43. Europe Mass Spectroscopy Market By Region, From 2019-2024 ( USD Million )
  44. Europe HPLC Market By Region, From 2019-2024 ( USD Million )
  45. Europe UPLC Market By Region, From 2019-2024 ( USD Million )
  46. Europe NMRS Market By Region, From 2019-2024 ( USD Million )
  47. Europe Surface Based analysis Market By Region, From 2019-2024 ( USD Million )
  48. Europe Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  49. Europe Oncology Market By Region, From 2019-2024 ( USD Million )
  50. Europe Cardiology Market By Region, From 2019-2024 ( USD Million )
  51. Europe Inborn Errors Market By Region, From 2019-2024 ( USD Million )
  52. Europe Metabolomics Market By Application, From 2019-2024 ( USD Million )
  53. Europe Nutrigenomics Market By Region, From 2019-2024 ( USD Million )
  54. Europe Toxicology Market By Region, From 2019-2024 ( USD Million )
  55. Europe Biomarker & Drug Discovery Market By Region, From 2019-2024 ( USD Million )
  56. U.K. Metabolomics Market By Product, From 2019-2024 ( USD Million )
  57. U.K. Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  58. U.K. Metabolomics Market By Application, From 2019-2024 ( USD Million )
  59. Germany Metabolomics Market By Product, From 2019-2024 ( USD Million )
  60. Germany Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  61. Germany Metabolomics Market By Application, From 2019-2024 ( USD Million )
  62. France Metabolomics Market By Product, From 2019-2024 ( USD Million )
  63. France Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  64. France Metabolomics Market By Application, From 2019-2024 ( USD Million )
  65. Italy Metabolomics Market By Product, From 2019-2024 ( USD Million )
  66. Italy Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  67. Italy Metabolomics Market By Application, From 2019-2024 ( USD Million )
  68. Spain Metabolomics Market By Product, From 2019-2024 ( USD Million )
  69. Spain Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  70. Spain Metabolomics Market By Application, From 2019-2024 ( USD Million )
  71. Asia-Pacific Metabolomics Market By Product, From 2019-2024 ( USD Million )
  72. Asia-Pacific GC Market By Region, From 2019-2024 ( USD Million )
  73. Asia-Pacific Bioinformatics Market By Region, From 2019-2024 ( USD Million )
  74. Asia-Pacific Mass Spectroscopy Market By Region, From 2019-2024 ( USD Million )
  75. Asia-Pacific HPLC Market By Region, From 2019-2024 ( USD Million )
  76. Asia-Pacific UPLC Market By Region, From 2019-2024 ( USD Million )
  77. Asia-Pacific NMRS Market By Region, From 2019-2024 ( USD Million )
  78. Asia-Pacific Surface Based analysis Market By Region, From 2019-2024 ( USD Million )
  79. Asia-Pacific Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  80. Asia-Pacific Oncology Market By Region, From 2019-2024 ( USD Million )
  81. Asia-Pacific Cardiology Market By Region, From 2019-2024 ( USD Million )
  82. Asia-Pacific Inborn Errors Market By Region, From 2019-2024 ( USD Million )
  83. Asia-Pacific Metabolomics Market By Application, From 2019-2024 ( USD Million )
  84. Asia-Pacific Nutrigenomics Market By Region, From 2019-2024 ( USD Million )
  85. Asia-Pacific Toxicology Market By Region, From 2019-2024 ( USD Million )
  86. Asia-Pacific Biomarker & Drug Discovery Market By Region, From 2019-2024 ( USD Million )
  87. Japan Metabolomics Market By Product, From 2019-2024 ( USD Million )
  88. Japan Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  89. Japan Metabolomics Market By Application, From 2019-2024 ( USD Million )
  90. China Metabolomics Market By Product, From 2019-2024 ( USD Million )
  91. China Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  92. China Metabolomics Market By Application, From 2019-2024 ( USD Million )
  93. India Metabolomics Market By Product, From 2019-2024 ( USD Million )
  94. India Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  95. India Metabolomics Market By Application, From 2019-2024 ( USD Million )
  96. Australia Metabolomics Market By Product, From 2019-2024 ( USD Million )
  97. Australia Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  98. Australia Metabolomics Market By Application, From 2019-2024 ( USD Million )
  99. South Korea Metabolomics Market By Product, From 2019-2024 ( USD Million )
  100. South Korea Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  101. South Korea Metabolomics Market By Application, From 2019-2024 ( USD Million )
  102. Latin America Metabolomics Market By Product, From 2019-2024 ( USD Million )
  103. Latin America GC Market By Region, From 2019-2024 ( USD Million )
  104. Latin America Bioinformatics Market By Region, From 2019-2024 ( USD Million )
  105. Latin America Mass Spectroscopy Market By Region, From 2019-2024 ( USD Million )
  106. Latin America HPLC Market By Region, From 2019-2024 ( USD Million )
  107. Latin America UPLC Market By Region, From 2019-2024 ( USD Million )
  108. Latin America NMRS Market By Region, From 2019-2024 ( USD Million )
  109. Latin America Surface Based analysis Market By Region, From 2019-2024 ( USD Million )
  110. Latin America Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  111. Latin America Oncology Market By Region, From 2019-2024 ( USD Million )
  112. Latin America Cardiology Market By Region, From 2019-2024 ( USD Million )
  113. Latin America Inborn Errors Market By Region, From 2019-2024 ( USD Million )
  114. Latin America Metabolomics Market By Application, From 2019-2024 ( USD Million )
  115. Latin America Nutrigenomics Market By Region, From 2019-2024 ( USD Million )
  116. Latin America Toxicology Market By Region, From 2019-2024 ( USD Million )
  117. Latin America Biomarker & Drug Discovery Market By Region, From 2019-2024 ( USD Million )
  118. Brazil Metabolomics Market By Product, From 2019-2024 ( USD Million )
  119. Brazil Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  120. Brazil Metabolomics Market By Application, From 2019-2024 ( USD Million )
  121. Argentina Metabolomics Market By Product, From 2019-2024 ( USD Million )
  122. Argentina Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  123. Argentina Metabolomics Market By Application, From 2019-2024 ( USD Million )
  124. Mexico Metabolomics Market By Product, From 2019-2024 ( USD Million )
  125. Mexico Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  126. Mexico Metabolomics Market By Application, From 2019-2024 ( USD Million )
  127. Rest of Latin America Metabolomics Market By Product, From 2019-2024 ( USD Million )
  128. Rest of Latin America Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  129. Rest of Latin America Metabolomics Market By Application, From 2019-2024 ( USD Million )
  130. Middle East & Africa Metabolomics Market By Product, From 2019-2024 ( USD Million )
  131. Middle East & Africa GC Market By Region, From 2019-2024 ( USD Million )
  132. Middle East & Africa Bioinformatics Market By Region, From 2019-2024 ( USD Million )
  133. Middle East & Africa Mass Spectroscopy Market By Region, From 2019-2024 ( USD Million )
  134. Middle East & Africa HPLC Market By Region, From 2019-2024 ( USD Million )
  135. Middle East & Africa UPLC Market By Region, From 2019-2024 ( USD Million )
  136. Middle East & Africa NMRS Market By Region, From 2019-2024 ( USD Million )
  137. Middle East & Africa Surface Based analysis Market By Region, From 2019-2024 ( USD Million )
  138. Middle East & Africa Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  139. Middle East & Africa Oncology Market By Region, From 2019-2024 ( USD Million )
  140. Middle East & Africa Cardiology Market By Region, From 2019-2024 ( USD Million )
  141. Middle East & Africa Inborn Errors Market By Region, From 2019-2024 ( USD Million )
  142. Middle East & Africa Metabolomics Market By Application, From 2019-2024 ( USD Million )
  143. Middle East & Africa Nutrigenomics Market By Region, From 2019-2024 ( USD Million )
  144. Middle East & Africa Toxicology Market By Region, From 2019-2024 ( USD Million )
  145. Middle East & Africa Biomarker & Drug Discovery Market By Region, From 2019-2024 ( USD Million )
  146. Middle East Metabolomics Market By Product, From 2019-2024 ( USD Million )
  147. Middle East Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  148. Middle East Metabolomics Market By Application, From 2019-2024 ( USD Million )
  149. Africa Metabolomics Market By Product, From 2019-2024 ( USD Million )
  150. Africa Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  151. Africa Metabolomics Market By Application, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample